Generation of recombinant lymphocytic choriomeningitis viruses with trisegmented genomes stably expressing two additional genes of interest
about
Arenavirus reverse genetics: new approaches for the investigation of arenavirus biology and development of antiviral strategiesReporter-Expressing, Replicating-Competent Recombinant ArenavirusesWidespread recombination, reassortment, and transmission of unbalanced compound viral genotypes in natural arenavirus infectionsTwo-photon imaging of microbial immunity in living tissues.Type I interferon suppresses virus-specific B cell responses by modulating CD8(+) T cell differentiationType I interferon is a therapeutic target for virus-induced lethal vascular damage.New vaccine design based on defective genomes that combines features of attenuated and inactivated vaccinesReplicating viral vector platform exploits alarmin signals for potent CD8+ T cell-mediated tumour immunotherapy.Design, synthesis, and biological evaluation of a biyouyanagin compound libraryRescue from cloned cDNAs and in vivo characterization of recombinant pathogenic Romero and live-attenuated Candid #1 strains of Junin virus, the causative agent of Argentine hemorrhagic fever disease.Hypomorphic mutation in the site-1 protease Mbtps1 endows resistance to persistent viral infection in a cell-specific manner.Selective inhibitor of endosomal trafficking pathways exploited by multiple toxins and viruses.Migration of cytotoxic lymphocytes in cell cycle permits local MHC I-dependent control of division at sites of viral infectionExpanded potential for recombinant trisegmented lymphocytic choriomeningitis viruses: protein production, antibody production, and in vivo assessment of biological function of genes of interest.Development of live-attenuated arenavirus vaccines based on codon deoptimizationRNAi screening reveals requirement for host cell secretory pathway in infection by diverse families of negative-strand RNA viruses.Single nucleoprotein residue modulates arenavirus replication complex formation.Identification and Mechanism of Action of a Novel Small-Molecule Inhibitor of Arenavirus Multiplication.The Nucleoprotein Is Required for Lymphocytic Choriomeningitis Virus-Based Vaccine Vector Immunogenicity.Type I and Type II Interferon Coordinately Regulate Suppressive Dendritic Cell Fate and Function during Viral PersistencePlasmacytoid dendritic cells are productively infected and activated through TLR-7 early after arenavirus infectionChemokine guidance of central memory T cells is critical for antiviral recall responses in lymph nodes.D471G mutation in LCMV-NP affects its ability to self-associate and results in a dominant negative effect in viral RNA synthesisMinigenomes, transcription and replication competent virus-like particles and beyond: reverse genetics systems for filoviruses and other negative stranded hemorrhagic fever virusesLessons learned and concepts formed from study of the pathogenesis of the two negative-strand viruses lymphocytic choriomeningitis and influenza.A Novel Live Pichinde Virus-Based Vaccine Vector Induces Enhanced Humoral and Cellular Immunity after a Booster Dose.Pathogenesis of Lassa fever virus infection: I. Susceptibility of mice to recombinant Lassa Gp/LCMV chimeric virus.Arenavirus reverse genetics for vaccine developmentNeuroprotective intervention by interferon-γ blockade prevents CD8+ T cell-mediated dendrite and synapse loss.Generation of recombinant arenavirus for vaccine development in FDA-approved Vero cells.pMHC affinity controls duration of CD8+ T cell-DC interactions and imprints timing of effector differentiation versus expansion.Reverse Genetics Approaches to Control Arenavirus.Development of live-attenuated arenavirus vaccines based on codon deoptimization of the viral glycoprotein.Human plasmacytoid dendritic cells sense lymphocytic choriomeningitis virus-infected cells in vitroCurrent drug discovery strategies against arenavirus infections.Novel drug discovery approaches for treating arenavirus infections.Residues K465 and G467 within the Cytoplasmic Domain of GP2 Play a Critical Role in the Persistence of Lymphocytic Choriomeningitis Virus in Mice.Creation of a recombinant Rift Valley fever virus with a two-segmented genome.Novel strategies for development of hemorrhagic fever arenavirus live-attenuated vaccines.Vaccine platforms to control Lassa fever.
P2860
Q24599295-C8F68318-144D-4BF2-801C-C0EB30526DCFQ26742028-08E9B9B0-23D3-4AAE-A002-E4BD32A9172FQ27319869-1D6E9E1A-157A-429B-AB1A-4082F6560C68Q30544651-3EFF32DD-B503-4204-B663-779EEEA14C8BQ30827049-6105820A-6B1C-48AD-B81F-1338A4ABD77EQ33415686-9766E69E-EC61-47D7-AF7D-859E13FC0AF0Q33573531-18F428B6-414F-4EEC-8A23-88F3918803B1Q33762986-0FE2E1C5-2F09-42FF-A012-F9862769ACCCQ33796299-1AFBB1D7-0AD7-4B9C-BED8-A51E706E6383Q34529751-0897267B-7A62-4010-9EB3-F2F80F4F8002Q34677940-B4F86F61-FD62-48CA-A6C5-024BADE30059Q35031738-17044152-980D-486D-AAC4-95B0D04E8161Q35102242-C5821473-F971-4D70-9B31-D072F0FA00ECQ35140212-783338F1-BD53-4C27-BEE3-FB1466ABE68EQ35487706-4DC07B9D-209F-4A43-B756-01FB595AC290Q35571345-375AA93C-3F25-41DE-9BA0-878F0D4D4FDAQ35620154-7D9F0C70-1D7B-4B41-9111-A023D8CA075AQ35751585-81C17468-430D-465B-BE6F-2024EA50229CQ35768790-C32BC5D6-A005-4F57-B4F2-96C903498294Q35903800-26F2092A-7D99-4166-AAA6-AEC394C530D8Q36041511-2EDF8847-D7B7-43CE-8DA0-78846C70F0B0Q36241951-98EDDBC8-F207-42E0-9FD0-BB127690FEFEQ36395857-FB4AF5EB-EC8D-4D83-88CF-249058C43912Q36650409-D8EC321B-540F-4958-84DB-CB3C487518D4Q36692797-5EF7E7E7-9F88-4EF3-AB35-11E606693746Q36736786-B20367C8-E65D-447F-A906-69969DF7BC2DQ36941000-63393479-5E05-4964-9802-3D899BCE2CDAQ37006773-A5ADA6AF-1CF0-4534-9828-0D9B9D822585Q37194982-3F805AEC-72AA-4B24-8F4B-4EBEB322BDB3Q37356067-822ED370-0381-4DC5-A615-ABF3EEFEF9EAQ37415209-BCFE974C-580A-4A5D-B7FF-689705728F31Q37543755-FEEBC5A0-462E-495C-9702-AA73E4CB914BQ37546745-ADFAE4A7-6D16-47BF-BDCC-A8EA7F140104Q37547599-D601DE51-1A19-461D-9EE5-10D28C4D61E4Q38067504-037407F2-9BB0-49AB-AAF1-C5326A5482AAQ38735837-60A00742-30FC-41A0-859C-33575AAEEB24Q38736159-8B675A9D-6668-4AA2-810D-CBB0DB1C98B1Q38748778-AF2B189A-ECDA-47DF-BEA8-D36A907BC0E0Q38818648-06E0FFF7-B9F1-41E3-939F-2172535D1D6EQ38823264-4FD2E876-15A6-48A5-9D50-BBE9095E432D
P2860
Generation of recombinant lymphocytic choriomeningitis viruses with trisegmented genomes stably expressing two additional genes of interest
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Generation of recombinant lymp ...... o additional genes of interest
@ast
Generation of recombinant lymp ...... o additional genes of interest
@en
Generation of recombinant lymp ...... o additional genes of interest
@nl
type
label
Generation of recombinant lymp ...... o additional genes of interest
@ast
Generation of recombinant lymp ...... o additional genes of interest
@en
Generation of recombinant lymp ...... o additional genes of interest
@nl
prefLabel
Generation of recombinant lymp ...... o additional genes of interest
@ast
Generation of recombinant lymp ...... o additional genes of interest
@en
Generation of recombinant lymp ...... o additional genes of interest
@nl
P2093
P2860
P3181
P356
P1476
Generation of recombinant lymp ...... o additional genes of interest
@en
P2093
Juan C de la Torre
Lucile Garidou
Sebastien F Emonet
P2860
P304
P3181
P356
10.1073/PNAS.0900088106
P407
P577
2009-02-10T00:00:00Z